Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: The antiarrhythmics versus implantable defibrillators (AVID) trial

Journal of the American College of Cardiology

Volumn 34, Issue 2, 1999, Pages 325-333

  Exner, Derek V ^a   Reiffel, James A ^c   Epstein, Andrew E ^c   Ledingham, Robert ^b   Reiter, Michael J ^c   Yao, Qing ^b   Duff, Henry J ^c   Follmann, Dean ^a   Schron, Eleanor ^a   Greene, H Leon ^b   Carlson, Mark D ^c   Brodsky, Michael A ^c   Akiyama, Toshio ^c   Baessler, Christina ^c   Anderson, Jeffrey L ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0032701152     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00234-X     Document Type: Article

References (33)

1. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 247:1982;1707-1714.
2. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 304:1981;801-807.
3. Heidenreich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure a meta-analysis of randomized clinical trials . J Am Coll Cardiol. 30:1997;27-34.
4. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
5. Cardiac Insufficiency Bisoprolol Study (CIBIS II) a randomised trial . Lancet. 353:1999;9-13.
6. Steinbeck G., Andresen D., Bach P., et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 327:1992;987-992.
7. Antz M., Cappato R., Kuck K.H. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. J Cardiovasc Pharmacol. 26:1995;627-635.
8. Hallstrom A.P., Cobb L.A., Yu B.H., Weaver W.D., Fahrenbruch C.E. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol. 68:1991;1025-1031.
9. Szabo B.M., Crijns H.J., Wiesfeld A.C., van Veldhuisen D.J., Hillege H.L., Lie K.I. Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function importance of beta-blockade . Am Heart J. 130:1995;281-286.
10. Julian D.G., Camm A.J., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 349:1997;667-674.
11. Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 349:1997;675-682.
12. Malik M., Camm A.J., Julian D.G., et al. Benefit of amiodarone vs. placebo in post-infarction patients with reduced heart rate variability is independent of concurrent beta-blocker treatment (Abstr). PACE. 20:(Suppl):1997;1144.
13. Janse M.J., Malik M., Camm A.J., Julian D.G., Frangin G.A., Schwartz P.J. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Eur Heart J. 19:1998;85-95.
14. Dorian P., Newman D., Connolly C., Roberts R., Gent M., Cairns J. Beta blockade may be necessary for amiodarone to exert its antiarrhythmic benefit - Results from CAMIAT (Abstr). PACE. 20:(Suppl):1997;1144.
15. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
16. Myerburg R.J., Castellanos A. Clinical trials of implantable defibrillators. N Engl J Med. 337:1997;1621-1623.
17. Antiarrhythmics Versus Implantable Defibrillators (AVID) rationale, design, and methods . Am J Cardiol. 75:1995;470-475.
18. Kim S.G., Hallstrom A., Love J.C., et al. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial and nonrandomized registry patients. Am J Cardiol. 80:1997;454-457.
19. Curtis A.B., Hallstrom A.P., Klein R.C., et al. Influence of patient characteristics in the selection of patients for defibrillator implantation (the AVID Registry). Antiarrhythmics Versus Implantable Defibrillators. Am J Cardiol. 79:1997;1185-1189.
20. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol. Submitted.
21. Levine J.H., Mellits E.D., Baumgardner R.A., et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 84:1991;558-566.
22. Leclercq J.F., Leenhardt A., Coumel P., Slama R. Efficacy of beta-blocking agents in reducing the number of shocks in patients implanted with first-generation automatic defibrillators. Eur Heart J. 13:1992;1180-1184.
23. Brodsky M.A., Allen B.J., Luckett C.R., Capparelli E.V., Wolff L.J., Henry W.L. Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmias. Am Heart J. 118:1989;272-280.
24. Singh B.N., Venkatesh N., Nademanee K., Josephson M.A., Kannan R. The historical development, cellular electrophysiology and pharmacology of amiodarone. Prog Cardiovasc Dis. 31:1989;249-280.
25. Crijns H.J., Wiesfeld A.C., Posma J.L., Lie K.I. Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias. Br Heart J. 74:1995;408-412.
26. Billman G.E., Castillo L.C., Hensley J., Hohl C.M., Altschuld R.A. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death . Circulation. 96:1997;1914-1922.
27. Krum H., Shusterman N., MacMahon S., Sharpe N. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. J Card Fail. 4:1998;281-288.
28. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med. 320:1989;618-627.
29. Herlitz J., Hjalmarson A., Swedberg K., et al. The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the Goteborg metoprolol trial. Int J Cardiol. 10:1986;291-301.
30. Kendall M.J., Lynch K.P., Hjalmarson A., Kjekshus J. Beta-blockers and sudden cardiac death. Ann Intern Med. 123:1995;358-367.
31. O'Rourke R.A. Role of myocardial revascularization in sudden cardiac death. Circulation. 85:1992;112-117.
32. Tonet J., Frank R., Fontaine G., Grosgogeat Y. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. PACE. 11:1988;1984-1989.
33. Ferguson J.J. Meeting highlights: 47th Annual Scientific Sessions of the American College of Cardiology. Preliminary results of the Cardiac Arrest Survival Hamburg (CASH) trial. Circulation. 97:1998;2377-2381.